738 related articles for article (PubMed ID: 32070069)
1. Interleukin-17A and Keratinocytes in Psoriasis.
Furue M; Furue K; Tsuji G; Nakahara T
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070069
[TBL] [Abstract][Full Text] [Related]
2. Development of psoriasis by continuous neutrophil infiltration into the epidermis.
Katayama H
Exp Dermatol; 2018 Oct; 27(10):1084-1091. PubMed ID: 30019426
[TBL] [Abstract][Full Text] [Related]
3. Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway.
Zhao J; Xie X; Di T; Liu Y; Qi C; Chen Z; Li P; Wang Y
Int Immunopharmacol; 2021 May; 94():107229. PubMed ID: 33611057
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome profiling unveils the role of cholesterol in IL-17A signaling in psoriasis.
Varshney P; Narasimhan A; Mittal S; Malik G; Sardana K; Saini N
Sci Rep; 2016 Jan; 6():19295. PubMed ID: 26781963
[TBL] [Abstract][Full Text] [Related]
5. CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ.
Gunderson AJ; Mohammed J; Horvath FJ; Podolsky MA; Anderson CR; Glick AB
J Invest Dermatol; 2013 Apr; 133(4):955-63. PubMed ID: 23151849
[TBL] [Abstract][Full Text] [Related]
6. Cyto/chemokine profile of in vitro scratched keratinocyte model: Implications of significant upregulation of CCL20, CXCL8 and IL36G in Koebner phenomenon.
Furue K; Ito T; Tanaka Y; Yumine A; Hashimoto-Hachiya A; Takemura M; Murata M; Yamamura K; Tsuji G; Furue M
J Dermatol Sci; 2019 Apr; 94(1):244-251. PubMed ID: 31010609
[TBL] [Abstract][Full Text] [Related]
7. The CCL20 and CCR6 axis in psoriasis.
Furue K; Ito T; Tsuji G; Nakahara T; Furue M
Scand J Immunol; 2020 Mar; 91(3):e12846. PubMed ID: 31692008
[TBL] [Abstract][Full Text] [Related]
8. The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients.
Furue K; Ito T; Tanaka Y; Hashimoto-Hachiya A; Takemura M; Murata M; Kido-Nakahara M; Tsuji G; Nakahara T; Furue M
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936670
[TBL] [Abstract][Full Text] [Related]
9. Leptin deficiency in mice counteracts imiquimod (IMQ)-induced psoriasis-like skin inflammation while leptin stimulation induces inflammation in human keratinocytes.
Stjernholm T; Ommen P; Langkilde A; Johansen C; Iversen L; Rosada C; Stenderup K
Exp Dermatol; 2017 Apr; 26(4):338-345. PubMed ID: 27488462
[TBL] [Abstract][Full Text] [Related]
10. Suppression of IL-17A-induced CCL20 production by cytokine inducible SH2-containing protein 1 in epidermal keratinocytes.
Tohyama M; Matsumoto A; Tsuda T; Dai X; Shiraishi K; Sayama K
J Dermatol Sci; 2021 Mar; 101(3):202-209. PubMed ID: 33509657
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis.
Furue K; Ulzii D; Tanaka Y; Ito T; Tsuji G; Kido-Nakahara M; Nakahara T; Furue M
J Dermatol; 2020 Sep; 47(9):979-988. PubMed ID: 32677165
[TBL] [Abstract][Full Text] [Related]
12. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF
Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123
[TBL] [Abstract][Full Text] [Related]
13. GRP78 Downregulation in Keratinocytes Promotes Skin Inflammation through the Recruitment and Activation of CCR6
Zhao L; Li J; Jiang B; Yang J; Lan J; Li D; Wen J; Xia Y; Nie W; Wang Z; Lv Y; Zeng F; Li Y; Shen G; Lei P; Tao J
J Invest Dermatol; 2024 Jul; 144(7):1557-1567.e11. PubMed ID: 38272207
[TBL] [Abstract][Full Text] [Related]
14. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.
Harper EG; Guo C; Rizzo H; Lillis JV; Kurtz SE; Skorcheva I; Purdy D; Fitch E; Iordanov M; Blauvelt A
J Invest Dermatol; 2009 Sep; 129(9):2175-83. PubMed ID: 19295614
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
Couderc E; Morel F; Levillain P; Buffière-Morgado A; Camus M; Paquier C; Bodet C; Jégou JF; Pohin M; Favot L; Garcia M; Huguier V; Mcheik J; Lacombe C; Yssel H; Guillet G; Bernard FX; Lecron JC
PLoS One; 2017; 12(7):e0181486. PubMed ID: 28708859
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation.
Xu X; Prens E; Florencia E; Leenen P; Boon L; Asmawidjaja P; Mus AM; Lubberts E
Front Immunol; 2021; 12():719562. PubMed ID: 34616394
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of psoriasis and development of treatment.
Ogawa E; Sato Y; Minagawa A; Okuyama R
J Dermatol; 2018 Mar; 45(3):264-272. PubMed ID: 29226422
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis
Liu XT; Shi ZR; Lu SY; Hong D; Qiu XN; Tan GZ; Xiong H; Guo Q; Wang L
Front Immunol; 2022; 13():817040. PubMed ID: 35401573
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17A affects extracellular vesicles release and cargo in human keratinocytes.
Mangino G; Iuliano M; Carlomagno S; Bernardini N; Rosa P; Chiantore MV; Skroza N; Calogero A; Potenza C; Romeo G
Exp Dermatol; 2019 Sep; 28(9):1066-1073. PubMed ID: 31373041
[TBL] [Abstract][Full Text] [Related]
20. Bcl-3 induced by IL-22 via STAT3 activation acts as a potentiator of psoriasis-related gene expression in epidermal keratinocytes.
Tohyama M; Shirakata Y; Hanakawa Y; Dai X; Shiraishi K; Murakami M; Miyawaki S; Mori H; Utsunomiya R; Masuda K; Hashimoto K; Sayama K
Eur J Immunol; 2018 Jan; 48(1):168-179. PubMed ID: 28901004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
